Results 11 to 20 of about 1,610 (149)

Update on alternative therapies for vulvovaginal atrophy

Patient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Although systemic absorption of estrogen with local treatment for vulvovaginal atrophy (VVA) is most likely to be negligible, it is ...
Chollet J
doaj   +5 more sources

Clinical and morphological aspects of vulvovaginal atrophy

Медицинский совет, 2014
Vulvovaginal atrophy is one of the most annoying and undesirable manifestations of estrogen deficiency. 77% of women feel uncomfortable to discuss the symptoms with their doctor.
I. A. Apolikhina, E. A. Gorbunova
doaj   +2 more sources

The effectiveness of rehabilitation in vulvovaginal atrophy

Фармакоэкономика
Objective: to evaluate the effectiveness and safety of rehabilitation programmes in patients with vulvovaginal atrophy (VVA).Material and methods. The study involved 350 patients with VVA in surgical (n=140) and natural (n=140) menopause, the control ...
D. М. Ampilogova, А. G. Solopova, D. V. Blinov, А. Е. Ivanov, S. V. Khlopkova, G. К. Bykovshchenko   +5 more
doaj   +2 more sources

Non-hormonal therapies for vulvovaginal atrophy: Clinical cases

Гинекология
Menopause is associated with a deficiency of sex hormones, which significantly impacts a woman's physical and psycho-emotional state. In particular, the blood supply to the genitourinary system organs deteriorates, and the synthesis of connective tissue ...
Tatiana B. Motovilova, Liya Z. Sirotina, Oksana I. Trifonova, Irina A. Kruglova, Anastasiya D. Varnavskaya, Kseniia V. Kazakova   +5 more
doaj   +2 more sources

Vulvovaginal Atrophy [PDF]

Mayo Clinic Proceedings, 2010
Vulvovaginal atrophy (VVA) is a common and underreported condition associated with decreased estrogenization of the vaginal tissue. Symptoms include dryness, irritation, soreness, and dyspareunia with urinary frequency, urgency, and urge incontinence. It can occur at any time in a woman's life cycle, although more commonly in the postmenopausal phase ...
Maire B, Mac Bride, Deborah J, Rhodes, Lynne T, Shuster   +2 more
openaire   +4 more sources

Vulvovaginal atrophy: current methods of diagnosis and treatment

Бюллетень сибирской медицины
Aim. To review modern methods of diagnosis and treatment of vulvovaginal atrophy (VVA), which is one of the manifestations of genitourinary syndrome of menopause in periand postmenopausal women.Materials and methods.
L. F. Zainetdinova, L. F. Telesheva, B. I. Medvedev, V. V. Khakhulina   +3 more
doaj   +2 more sources

Vulvovaginal atrophy in postmenopausal women: diagnosis and modern-day treatments

Лечащий Врач, 2022
The article is devoted to the study of modern methods of diagnosis and treatment of benign diseases of the vulva and vagina in postmenopausal women.
K. R. Bahtiyarov, R. A. Chilova, Sh. Sh. Sardarova   +2 more
doaj   +1 more source

Vulvovaginal atrophy: issues of treatment and rehabilitation: A review [PDF]

Гинекология, 2022
The review presents data on the management tactics of women with vulvovaginal atrophy in patients of reproductive age and menopause. The influence of vulvovaginal atrophy on the psycho-emotional and sexual spheres, modern methods of diagnosis and therapy
Diana M. Ampilogova, Antonina G. Solopova, Dmitry V. Blinov, Evgeny E. Achkasov, Daria A. Petrenko, Daniil I. Korabelnikov   +5 more
doaj   +1 more source

The Role of Topical Treatment on Vaginal Tightening

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2022
Background: Physiological changes in a woman's life, such as labor, weight fluctuations, hormonal changes, aging, and menopause, cause changes in both appearance and function of the vagina.
Made Putri Hendaria
doaj   +1 more source

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

Menopause Review, 2021
During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep.
Wojciech Pięta, Roman Smolarczyk
doaj   +1 more source